[Research development of polylactide and its composites in bone-tissue engineering]

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Polymer Science

Background:

• Polylactide (PLA) is an FDA-approved polymer known for its biocompatibility and biodegradability.
• PLA serves as a promising scaffold material in regenerative medicine, particularly for bone repair.
• The integration of fillers like hydroxylapatite (HA) and bioactive organic materials can enhance PLA's properties for bone-tissue engineering.

Purpose of the Study:

• To review the current research and development in applying polylactide (PLA) and its composites in bone-tissue engineering.
• To highlight the advancements in using hydroxylapatite/PLA and bioactive organic materials/PLA composites.
• To provide insights into the potential of these materials for bone regeneration.

Main Methods:

• Literature review of scientific publications on polylactide and its composites in bone-tissue engineering.
• Analysis of studies focusing on material properties, biocompatibility, and in vivo/in vitro performance.
• Synthesis of information regarding the application of HA/PLA and bioactive organic materials/PLA composites.

Main Results:

• Polylactide (PLA) demonstrates significant potential as a base material for bone-tissue engineering scaffolds.
• Hydroxylapatite (HA)/PLA composites show improved mechanical properties and osteoconductivity compared to pure PLA.
• Bioactive organic materials/PLA composites offer enhanced biological responses, promoting bone regeneration.

Conclusions:

• Polylactide (PLA) and its composites, including HA/PLA and bioactive organic materials/PLA, are highly suitable for bone-tissue engineering.
• These materials offer a tunable platform for developing effective bone regeneration strategies.
• Further research into optimizing composite formulations and understanding long-term biological interactions is warranted.